Delivery Order SPE2DB22D1106-SPE2DB24FEQH9
Award Date
5/6/24
Potential Completion Date
5/7/24
Potential Value
$8.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens by Amerisourcebergen Drug Corp to the U.S. government's Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $4,612.53 and a completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 ml) to the Defense Logistics Agency (DLA), a defense agency. The $7,177.37 firm fixed price contract was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, on June 27, 2024, with a completion date of June 28, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,610.97 and a completion date of December 17, 2024. It is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 mL) to the Defense Logistics Agency (DLA). The $32,903.29 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 5, 2024 and was not designated with a set-aside requirement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency. The contract has a ceiling value of $1,091.88 and a performance period through January 31, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc. The contract was awarded as a firm fixed-price...
This federal contract award is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,483.24, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 5, 2024 with a completion date of September 6, 2024. The contract is a delivery order with a firm fixed price pricing type. There is no set-aside designation mentioned. AmerisourceBergen holds significant Indefinite Delivery...
This federal contract award is for the delivery of the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL to the Defense Logistics Agency (DLA). The $10,643.71 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 5, 2024, with a completion date of August 6, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 mL) to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award has a ceiling value of $1,700.18 and is a firm fixed-price Delivery Order with a completion date of November 29, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Ozempic 0.25-0.5 mg/dose pens in 3 ml quantities. The award, valued at $1,753.22, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 16, 2024. The contract has a firm fixed-price delivery order type and an ultimate completion date of May 17, 2024. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA). The contract, valued at $16,575.36, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of June 26, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of...